Prevalence of atrial fibrillation (AFib) in patients with end-stage COPD increased by over 8% in a 12-year period, a fact that demands improved treatment options.
[maxbutton id=”1″ url=”http://info.respiratory-therapy.com/regform” text=”SUBSCRIBE TO NEWS” ]
Out of a total 1,345,270 patients, 18.2% had AFib, and the prevalence increased from 12.9% to 21.3% between 2003 and 2014, varying between sex, age, income, race, hospital region and insurance type.
Increased odds of AFib were associated with advancing age, white race, high income, female sex, and large hospital size.
